Protalix BioTherapeutics (PLX) EPS (Diluted) (QoQ) (2011 - 2026)
Protalix BioTherapeutics (PLX) EPS (Diluted) (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Protalix BioTherapeutics | 190.95 Mn | 180.16 Mn | 29.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 585.24% |
| Dec 31, 2025 | -252.75% |
| Sep 30, 2025 | 514.60% |
| Jun 30, 2025 | 110.29% |
| Mar 31, 2025 | -135.43% |
| Dec 31, 2024 | 211.85% |
| Sep 30, 2024 | 242.26% |
| Jun 30, 2024 | 52.23% |
| Mar 31, 2024 | 74.23% |
| Dec 31, 2023 | -1,004.52% |
| Sep 30, 2023 | -111.35% |
| Jun 30, 2023 | 457.65% |
| Mar 31, 2023 | 17.75% |
| Dec 31, 2022 | 8.10% |
| Sep 30, 2022 | 36.06% |
| Jun 30, 2022 | -126.02% |
| Mar 31, 2022 | 62.23% |
| Dec 31, 2021 | -40.05% |
| Sep 30, 2021 | 62.32% |
| Jun 30, 2021 | -70.48% |